Grant: Discovery Grants Program - Individual
University of Toronto
$37,000.00
Development of Wearable Devices for Continuous Vasomodulatory Monitoring
EF 2023-24
Résumé
Heart failure and related cardiovascular diseases are the leading cause of death in Canada and currently cost $7.6B/year for the Ontario Healthcare System. Reducing the human and financial cost of heart failure requires new approaches in detection, remote management, and intervention. Currently, patients must travel to the clinic several times a year for cardiac assessments - 34.6 million occur per year in total. However, treatment and monitoring options outside of clinical visits are limited, leading to a demand for remote/home monitoring solutions. The proposed 5-year research program will develop innovative wearable electronic devices that monitor physiological correlates of heart failure - facilitating improved remote management of the disease. This work will create optomechanical models linking wearable device measurements to physiology, develop novel wearable devices, and evaluate the technology and models in `real life' scenarios. The outcomes of this engineering program will enable future efforts in improved, real-time quantification of heart failure and allow earlier intervention, reduce hospitalizations, and improve the outcomes of Canadians facing heart failure.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-05525
Name nom
Franklin, Daniel
Department département
Institute of Biomedical Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
37000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2506
Research subject group en
Electrical and electronic engineering
Research subject group fr
Electron devices
Research subject en
Génie électrique et électronique
Research subject fr
Dispositifs électroniques
Application title
Development of Wearable Devices for Continuous Vasomodulatory Monitoring
Keyword
Algorithms; Biometrics; Hemodynamics; Numerical Simulations; Optomechanical Modeling; Photonics; Spectroscopy; Systems Integration; Vasomodulation; Wearables
Application summary
Heart failure and related cardiovascular diseases are the leading cause of death in Canada and currently cost $7.6B/year for the Ontario Healthcare System. Reducing the human and financial cost of heart failure requires new approaches in detection, remote management, and intervention. Currently, patients must travel to the clinic several times a year for cardiac assessments - 34.6 million occur per year in total. However, treatment and monitoring options outside of clinical visits are limited, leading to a demand for remote/home monitoring solutions. The proposed 5-year research program will develop innovative wearable electronic devices that monitor physiological correlates of heart failure - facilitating improved remote management of the disease. This work will create optomechanical models linking wearable device measurements to physiology, develop novel wearable devices, and evaluate the technology and models in `real life' scenarios. The outcomes of this engineering program will enable future efforts in improved, real-time quantification of heart failure and allow earlier intervention, reduce hospitalizations, and improve the outcomes of Canadians facing heart failure.